“…The target molecule in this study was protein A, which is a surface protein on the cell wall of Staphylococcus aureus . This bacterial protein is the most important ligand used in commercial activities for the purification of monoclonal antibodies (Palombo, Falco, Tortora, Cassani, & Fassina, ; Alkan, Bereli, Baysal, & Denizli, ; Satzer & Jungbauer, ; Tustian, Endicott, Adams, Mattila, & Bak, ; Salimi, Usta, Koçer, Çelik, & Tuncel, ; Pan, Xue, Wang, Xie, & Wu, ; Xue, Pan, Xie, Wang, & Zhang, ). Since publication of the first reports of the use of protein A as a stationary phase to purify antibodies more than 40 years ago, protein A has become the industry standard for monoclonal antibody purification for clinical use (Brechmann et al, ; Butcher et al, ).…”